[EN] THIAZOLIDINEDIONE DERIVATIVES AS ALPHA ADRENERGIC RECEPTOR ANTAGONISTS<br/>[FR] DERIVES DE THIAZOLIDINEDIONE
申请人:RANBAXY LAB LTD
公开号:WO2006013445A3
公开(公告)日:2006-04-27
[EN] THIAZOLIDINEDIONE DERIVATIVES<br/>[FR] DERIVES DE THIAZOLIDINEDIONE
申请人:RANBAXY LAB LTD
公开号:WO2006013445A2
公开(公告)日:2006-02-09
The present invention relates to alpha 1a and/or alpha 1d adrenergic receptor antagonists. Compounds described can function as alpha 1a and/or alpha 1d adrenergic receptor antagonists and can be used to treat diseases or disorders mediated through alpha 1a and/or alpha 1d adrenergic receptors. Compounds described can also be used to treat benign prostatic hyperplasia or related symptoms thereof. Compounds described can also be used to treat lower urinary tract symptoms associated with or without benign prostatic hyperplasia. Also described are processes to prepare the described compounds, as well as pharmaceutical compositions thereof and methods of treating benign prostatic hyperplasia or related symptoms thereof.
Recyclization reactions of small rings. 8. Synthesis of 5-substituted 2-oxazolidones from thiazolidine-2,4-dione and oxiranes